Ethics and Confidentiality
At the end of this activity the learner should be more competent in applying appropriate ethical and confidentiality principles, laws and regulations to the practice of addiction medicine, including the following:
- HIPPA regulations pertaining to confidentiality, for under-age minor versus adult patients, specifically concerning addiction and mental health disorders.
- Concepts and regulations relating to record-keeping, patient privacy and security of records, including the limitations and privacy expectations of 42CFR in integrated settings.
- Jurisprudence related to addiction and the practice of addiction medicine including the concepts of res ipsa loquitr, mens rea, and prima facia evidence.
- Typical malpractice pitfalls facing the addiction medicine provider, such as distinguishing between prescribing opiates for the treatment of pain versus the treatment of addiction, and issues that arise when prescribing pain control medications to persons with addictive disorders.
- Discussion of ethical issues specific to the field of addiction medicine
David Y Kan, MD
Dr. David Kan is Medical Director of the Opiate Replacement Therapy Clinic at the San Francisco VA Medical Center and a Assistant Clinical Professor at UC San Francisco. His areas of special clinical and forensic psychiatric interest include substance abuse, violence and suicide risk assessment, medical malpractice, assessment of sexual offenders, electroconvulsive therapy and impaired professionals. Dr. Kan has served a forensic expert in many cases and has been qualified as an expert in the San Francisco Court system on over 30 occasions. He is active in CSAM serving as the Chair of the Opiate Committee and a member of the public policy committee.
Dr. Kan has no relevant financial relationships to disclose.
- 1.00 California Board of Behavioral Sciences
- 1.00 NCCPA
- 1.00 AAPA
- 1.00 AMA Category 1
- 1.00 CAADAC